In a dispute over a drug bid by the Japan Community Health Care Organization, a person in charge of a major pharmaceutical wholesale company admitted the suspicion and explained that he did not want to reduce the share of the order amount. I found out by interviewing the people concerned.
On the 9th, the Japan Fair Trade Commission is expected to file criminal charges against the three major companies and the persons in charge of each company on suspicion of violating the Antimonopoly Act.
Regarding the bids for drugs in 57 hospitals operated by the independent administrative agency "Community Medical Function Promotion Organization", four major drug wholesalers "Mediceo", "Alfresa", "Toho Pharmaceutical", and "Suzuken" In October, the Tokyo District Inspection Special Investigation Department and the Fair Trade Commission are searching the head offices of each company, alleging that they suspected that they had negotiated with the contractor in advance four years ago.
According to the people concerned, it was the executives of each company who were in charge of allocating orders, and in response to the investigation by the Fair Trade Commission, multiple persons in charge said, "While I am in charge, each drug manufacturer I didn't want to lose the share of the order amount of the company. "
Since each company has admitted the charges, the Fair Trade Commission has filed criminal charges against the three companies except "Mediceo" who first declared fraud and the person in charge of each on the 9th on suspicion of violating the Antimonopoly Act. , The Special Investigation Department is expected to prosecute the three corporations and the persons in charge at home in response to the accusation.